New Drug Combats Multidrug Resistant Tuberculosis

    loading  Checking for direct PDF access through Ovid


Bedaquiline (Sirturo) is a new drug to treat multidrug-resistant pulmonary tuberculosis. It is administered as part of multidrug therapy when other antitubercular therapy cannot be used.Bedaquiline increases the risk of death and can prolong the QT interval, producing serious ventricular arrhythmias.

    loading  Loading Related Articles